Zevra Therapeutics Q1 EPS $0.60 Beats $0.07 Estimate, Sales $36.220M Beat $31.960M Estimate

Benzinga Newsdesk www.benzinga.com Positive 77.9%

Neg 0% Neu 0% Pos 77.9%

Comments

No comments yet. Be the first!